Frazier Healthcare Partners
Healthcare-focused private equity firm making Growth Buyout investments in U.S. middle-market healthcare companies and investing in biopharmaceutical discovery and development.
Frazier Healthcare Partners is a healthcare-focused private equity firm operating since 1991, managing two distinct investment platforms. The Healthcare Partners platform pursues Growth Buyout investments in profitable U.S. middle-market healthcare businesses, while Frazier Life Sciences invests across private and public companies engaged in biopharmaceutical discovery, development, and commercialization.
The firm employs a thesis-driven investment methodology paired with operational support infrastructure designed to drive value creation. Portfolio companies benefit from embedded executives in residence and a Center of Excellence providing functional expertise in growth and transformation activities. This hands-on operational model distinguishes the investment approach from traditional passive ownership structures.
Healthcare Partners targets established, cash-generative businesses within the U.S. middle market, where Frazier's domain expertise and operational resources can effect measurable improvements. Frazier Life Sciences extends this operational competency into earlier-stage biopharma investments, leveraging the firm's deep sectoral knowledge across both public and private markets.